LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
about
The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescuePlasma cholesterol-lowering and transient liver dysfunction in mice lacking squalene synthase in the liverApolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models.Polyphenol-rich bilberry ameliorates total cholesterol and LDL-cholesterol when implemented in the diet of Zucker diabetic fatty rats.Serum TG-lowering properties of plant sterols and stanols are associated with decreased hepatic VLDL secretion.Delineation of molecular pathways that regulate hepatic PCSK9 and LDL receptor expression during fasting in normolipidemic hamstersInhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi GranuleHepatic fatty acid trafficking: multiple forks in the roadApolipoprotein B secretion is regulated by hepatic triglyceride, and not insulin, in a model of increased hepatic insulin signaling.n-3 fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice.Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action.Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster modelAssociations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis.Egg consumption and insulin metabolism in the Insulin Resistance Atherosclerosis Study (IRAS).Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE(-/-) mice.Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.Chemical genetic-based phenotypic screen reveals novel regulators of gluconeogenesis in human primary hepatocytes
P2860
Q27022615-0542FB62-3F04-4134-99FA-5842B5E27E84Q28258554-813800E0-5F15-48CD-A2E6-F1CB68503FF6Q33858526-A2740F30-CA58-4A69-B616-A109B6571372Q33863614-32915D8E-E52D-49D5-90F1-466F138BA606Q34067485-23948251-B963-455D-B73F-286A28AE09AAQ34159251-D92CD9D9-6715-4027-B461-FC9F017EAB52Q34565258-6FF9C5E9-95D9-46AC-B85C-1EE1726312DBQ35927759-C2984321-C58B-4083-9D2C-F08B5BF0A7F5Q36896403-CF42F0DD-629C-48F2-9ED9-7010C18D7367Q37296476-88F932FA-FE7C-421D-A980-21F91F3D51A7Q37408615-5EEB9A38-BFC9-407A-B609-FC4B429D3FA3Q38747596-86F697E8-9DF8-43B8-B952-DF91341676D8Q39432694-9BD830BD-378F-4C0C-819D-C4AF41C1B236Q39710752-07C6DAD1-9FAD-4688-BAC0-D58C51FCC598Q41625507-1BA229B6-8DD0-4965-A5AD-14EA0F4F6578Q45138556-D128F983-0F6E-4B3E-84AE-393347AB323FQ54494709-0D770D28-38D7-4DEE-AC32-20FF5D15A156Q55425011-9B63E89D-9D05-45C6-AA45-53675A63C960Q58778375-0B942E56-EE32-493D-8BC5-3E372C55D9EC
P2860
LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
LXRalpha activation perturbs h ...... ein B-containing lipoproteins.
@en
LXRalpha activation perturbs h ...... ein B-containing lipoproteins.
@nl
type
label
LXRalpha activation perturbs h ...... ein B-containing lipoproteins.
@en
LXRalpha activation perturbs h ...... ein B-containing lipoproteins.
@nl
prefLabel
LXRalpha activation perturbs h ...... ein B-containing lipoproteins.
@en
LXRalpha activation perturbs h ...... ein B-containing lipoproteins.
@nl
P2093
P2860
P356
P1476
LXRalpha activation perturbs h ...... ein B-containing lipoproteins.
@en
P2093
Abigale Miller
Chris Baker
Heather Basciano
Khosrow Adeli
Mark Naples
P2860
P304
P356
10.1152/AJPGI.90546.2008
P577
2009-06-04T00:00:00Z